Anti-VEGF monotherapy treatment strategies for neovascular AMD

Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid Scott

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

Original languageEnglish (US)
Title of host publicationStudies on Retinal and Choroidal Disorders
PublisherHumana Press Inc.
Pages479-499
Number of pages21
ISBN (Electronic)9781617796067
ISBN (Print)9781617796050
DOIs
StatePublished - Jan 1 2012

Fingerprint

Vascular Endothelial Growth Factor A
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kovach, J. L., Schwartz, S. G., Flynn, H. W., & Scott, I. (2012). Anti-VEGF monotherapy treatment strategies for neovascular AMD. In Studies on Retinal and Choroidal Disorders (pp. 479-499). Humana Press Inc.. https://doi.org/10.1007/978-1-61779-606-7_23
Kovach, Jaclyn L. ; Schwartz, Stephen G. ; Flynn, Harry W. ; Scott, Ingrid. / Anti-VEGF monotherapy treatment strategies for neovascular AMD. Studies on Retinal and Choroidal Disorders. Humana Press Inc., 2012. pp. 479-499
@inbook{473b483eb9e2461096d7b8ac0e8d2f21,
title = "Anti-VEGF monotherapy treatment strategies for neovascular AMD",
abstract = "This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.",
author = "Kovach, {Jaclyn L.} and Schwartz, {Stephen G.} and Flynn, {Harry W.} and Ingrid Scott",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-61779-606-7_23",
language = "English (US)",
isbn = "9781617796050",
pages = "479--499",
booktitle = "Studies on Retinal and Choroidal Disorders",
publisher = "Humana Press Inc.",

}

Kovach, JL, Schwartz, SG, Flynn, HW & Scott, I 2012, Anti-VEGF monotherapy treatment strategies for neovascular AMD. in Studies on Retinal and Choroidal Disorders. Humana Press Inc., pp. 479-499. https://doi.org/10.1007/978-1-61779-606-7_23

Anti-VEGF monotherapy treatment strategies for neovascular AMD. / Kovach, Jaclyn L.; Schwartz, Stephen G.; Flynn, Harry W.; Scott, Ingrid.

Studies on Retinal and Choroidal Disorders. Humana Press Inc., 2012. p. 479-499.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Anti-VEGF monotherapy treatment strategies for neovascular AMD

AU - Kovach, Jaclyn L.

AU - Schwartz, Stephen G.

AU - Flynn, Harry W.

AU - Scott, Ingrid

PY - 2012/1/1

Y1 - 2012/1/1

N2 - This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

AB - This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

UR - http://www.scopus.com/inward/record.url?scp=85027317395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027317395&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-606-7_23

DO - 10.1007/978-1-61779-606-7_23

M3 - Chapter

AN - SCOPUS:85027317395

SN - 9781617796050

SP - 479

EP - 499

BT - Studies on Retinal and Choroidal Disorders

PB - Humana Press Inc.

ER -

Kovach JL, Schwartz SG, Flynn HW, Scott I. Anti-VEGF monotherapy treatment strategies for neovascular AMD. In Studies on Retinal and Choroidal Disorders. Humana Press Inc. 2012. p. 479-499 https://doi.org/10.1007/978-1-61779-606-7_23